NEWS: Curebase closes $40M Series B with strategic investment by Gilead. Read about it in TechCrunch, Fierce Biotech, andEndpoints News.

Expanding patient access with virtual site model and digital recruitment in cancer mental health DTx study

lorem ipsum

Get the case study

Blue Note Therapeutics was looking to recruit close to 400 patients in a fully-remote randomized controlled trial investigating a prescription digital therapeutic to treat anxiety and depression in oncology patients.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
335 S Van Ness Ave, San Francisco, CA,
94103-3627, United States